BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22310439)

  • 21. The Use of VTE prophylaxis in relatioN to patiEnt risk profiling (TUNE-IN) Wave 2 study.
    Jacobson BF; Louw S; Riback W
    S Afr Med J; 2014 Nov; 104(12):880-884. PubMed ID: 28375075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
    Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
    J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients.
    Pannucci CJ; Obi A; Alvarez R; Abdullah N; Nackashi A; Hu HM; Bahl V; Henke PK
    J Am Coll Surg; 2014 May; 218(5):898-904. PubMed ID: 24680577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism in Germany: results of the GermAn VTE registry (GATE-registry).
    Kröger K; Moerchel C; Bus C; Serban M
    Int J Clin Pract; 2014 Dec; 68(12):1467-72. PubMed ID: 25333964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who Should Get Extended Thromboprophylaxis After Bariatric Surgery?: A Risk Assessment Tool to Guide Indications for Post-discharge Pharmacoprophylaxis.
    Aminian A; Andalib A; Khorgami Z; Cetin D; Burguera B; Bartholomew J; Brethauer SA; Schauer PR
    Ann Surg; 2017 Jan; 265(1):143-150. PubMed ID: 28009739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs).
    Chamoun N; Matta S; Aderian SS; Salibi R; Salameh P; Tayeh G; Haddad E; Ghanem H
    Sci Rep; 2019 Dec; 9(1):18366. PubMed ID: 31797897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism following primary total hip arthroplasty.
    Hitos K; Fletcher JP
    Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The PROMET study: Prophylaxis for venous thromboembolic disease in at-risk patients hospitalized in Algeria].
    Guermaz R; Belhamidi S; Amarni A
    J Mal Vasc; 2015 Jul; 40(4):240-7. PubMed ID: 26051861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.
    Zhou H; Hu Y; Li X; Wang L; Wang M; Xiao J; Yi Q
    J Atheroscler Thromb; 2018 Nov; 25(11):1091-1104. PubMed ID: 29540637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery.
    McLynn RP; Diaz-Collado PJ; Ottesen TD; Ondeck NT; Cui JJ; Bovonratwet P; Shultz BN; Grauer JN
    Spine J; 2018 Jun; 18(6):970-978. PubMed ID: 29056565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.
    Bâ SA; Badiane SB; Diop SN; Diouf FS; Fall D; Ka MM; Kane A; Ndiaye M;
    Arch Cardiovasc Dis; 2011 Oct; 104(10):493-501. PubMed ID: 22044701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism in hospitalized patients--are we doing enough to prevent it? Commentary to the ENDORSE trial.
    Anderson FA
    Pol Arch Med Wewn; 2008 Oct; 118(10):536-7. PubMed ID: 19112811
    [No Abstract]   [Full Text] [Related]  

  • 35. Venous Thromboembolism Incidence After Craniofacial Surgery.
    Omesiete WI; Walker JA; Yu JC
    Ann Plast Surg; 2018 May; 80(5):561-564. PubMed ID: 29443835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients.
    Panju M; Raso D; Patel A; Panju A; Ginsberg J
    J R Coll Physicians Edinb; 2011 Dec; 41(4):304-8. PubMed ID: 22184567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An observational study for venous thromboembolism risk assessment among hospitalized patients in general surgery clinics across Turkey.
    Kurtoglu M;
    Phlebology; 2011 Dec; 26(8):344-52. PubMed ID: 21821721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis.
    Kinnier CV; Ju MH; Kmiecik T; Barnard C; Halverson T; Yang AD; Caprini J; Kreutzer L; Bilimoria KY
    Med Care; 2016 Feb; 54(2):210-7. PubMed ID: 26683781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
    Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.
    Bergqvist D; Arcelus JI; Felicissimo P;
    Thromb Haemost; 2012 Feb; 107(2):280-7. PubMed ID: 22186771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.